Clinical Study Results
Research Sponsor: AstraZeneca
Treatments Studied: 
- AZD4635 with durvalumab
- AZD4635 with oleclumab
Study Purpose: This study was done to learn if AZD4635, with durvalumab or with oleclumab, is safe and works in participants with prostate cancer
Protocol Number: D8731C00001
Thank you
Thank you for taking part in the clinical study for the study treatments AZD4635 with durvalumab and AZD4635 with oleclumab. You and all of the participants helped researchers learn more about AZD4635 with durvalumab or with oleclumab to help people with prostate cancer. AstraZeneca sponsored this study and believes it is important to share the results of the study with you and the public. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you. We hope it helps you understand and feel proud of your important role in medical research. If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.